Olga Sokolova

Prof. Olga Sokolova

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
YEYuri Efremov
Yuri Efremov
ADA.A. Dokrunova
A.A. Dokrunova
AEA.V. Efremenko
A.V. Efremenko
MKMikhail P. Kirpichnikov
Mikhail P. Kirpichnikov
KSK.V. Shaitan
K.V. Shaitan
OSOlga Sokolova
Olga Sokolova

12 October 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DGDaria A. Gaykalova
Daria A. Gaykalova
OKOlga I. Kulaeva
Olga I. Kulaeva
OVOlesya Volokh
Olesya Volokh
ASAlexey K. Shaytan
Alexey K. Shaytan
FHFu-Kai Hsieh
Fu-Kai Hsieh
VSVasily Studitsky
Vasily Studitsky
Thousands of human and Drosophila genes are regulated at the level of transcript elongation and nucleosomes are likely targets for this regulation. However, the molecular mechanisms of formation of the nucleosomal barrier to transcribing RNA polymerase II (Pol II) and nucleosome survival during/after transcription remain unknown. Here we show that both DNA–histone interactions and Pol II backtracking contribute to formation of the barrier and that nucleosome survival during transcription likely occurs through allosterically stabilized histone–histone interactions. Structural analysis indicates that after Pol II encounters the barrier, the enzyme backtracks and nucleosomal DNA recoils on the octamer, locking Pol II in the arrested state. DNA is displaced from one of the H2A/H2B dimers that remains associated with the octamer. The data reveal the importance of intranucleosomal DNA–protein and protein–protein interactions during conformational changes in the nucleosome structure on transcription. Mechanisms of nucleosomal barrier formation and nucleosome survival during transcription are proposed.

7 October 2008 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
VBVladimir Bogush
Vladimir Bogush
OSOlga Sokolova
Olga Sokolova
LDLyubov I Davydova
Lyubov I Davydova
DKDmitri V Klinov
Dmitri V Klinov
KSKonstantin V Sidoruk
Konstantin V Sidoruk
MKMikhail P Kirpichnikov
Mikhail P Kirpichnikov

1 May 2012 in Biomaterials
Verified
Journal Article
Closed access
MMMikhail M. Moisenovich
Mikhail M. Moisenovich
OPOlga Pustovalova
Olga Pustovalova
JSJulia Shackelford
Julia Shackelford
TVTamara V. Vasiljeva
Tamara V. Vasiljeva
TDTatiana V. Druzhinina
Tatiana V. Druzhinina
IAIgor I. Agapov
Igor I. Agapov

15 December 2014 in Acta Naturae
Verified
Journal Article
Open access
Anastasiia GrizelAnastasiia Grizel
Anastasiia Grizel
GGG. S. Glukhov
G. S. Glukhov
OSOlga Sokolova
Olga Sokolova
Voltage-gated potassium ion channels (Kv) play an important role in a variety of cellular processes, including the functioning of excitable cells, regulation of apoptosis, cell growth and differentiation, the release of neurotransmitters and hormones, maintenance of cardiac activity, etc. Failure in the functioning of Kv channels leads to severe genetic disorders and the development of tumors, including malignant ones. Understanding the mechanisms underlying Kv channels functioning is a key factor in determining the cause of the diseases associated with mutations in the channels, and in the search for new drugs. The mechanism of activation of the channels is a topic of ongoing debate, and a consensus on the issue has not yet been reached. This review discusses the key stages in studying the mechanisms of functioning of Kv channels and describes the basic models of their activation known to date.

1 January 2017 in Journal of Molecular Biology
Verified
Journal Article
Open access
OSOlga Sokolova
Olga Sokolova
ACAngelina Chemeris
Angelina Chemeris
SGSiyang Guo
Siyang Guo
SASalvatore L. Alioto
Salvatore L. Alioto
MGMeghal Gandhi
Meghal Gandhi
BGBruce L. Goode
Bruce L. Goode
The evolutionarily conserved Arp2/3 complex plays a central role in nucleating the branched actin filament arrays that drive cell migration, endocytosis, and other processes. To better understand Arp2/3 complex regulation, we used single-particle electron microscopy to compare the structures of Arp2/3 complex bound to three different inhibitory ligands: glia maturation factor (GMF), Coronin, and Arpin. Although the three inhibitors have distinct binding sites on Arp2/3 complex, they each induced an "open" nucleation-inactive conformation. Coronin promoted a standard (previously described) open conformation of Arp2/3 complex, with the N-terminal β-propeller domain of Coronin positioned near the p35/ARPC2 subunit of Arp2/3 complex. GMF induced two distinct open conformations of Arp2/3 complex, which correlated with the two suggested binding sites for GMF. Furthermore, GMF synergized with Coronin in inhibiting actin nucleation by Arp2/3 complex. Arpin, which uses VCA-related acidic (A) motifs to interact with the Arp2/3 complex, induced the standard open conformation, and two new masses appeared at positions near Arp2 and Arp3. Furthermore, Arpin showed additive inhibitory effects on Arp2/3 complex with Coronin and GMF. Together, these data suggest that Arp2/3 complex conformation is highly polymorphic and that its activities can be controlled combinatorially by different inhibitory ligands.